Quality · Access · Hope
Countries

🇩🇰 Country Profile

Denmark

Fast-growing pharmaceutical trade with Denmark

🇩🇰 $28.2M
Dual-source profile. Both series show finished pharmaceutical products aligned to calendar year (Jan–Dec). Eurostat records what Denmark imports from India. DGCIS records what India exports to Denmark. Category and product detail from DGCIS.
$28.2M
Scale
India supplies $28.2M in pharmaceutical products to Denmark — affordable medicine reaching Europe.
78%
Medicine
Overwhelmingly finished medicines — drug formulations account for 78% of shipments.
3.2×
Trajectory
Rapid expansion: Denmark's imports of Indian pharmaceutical products have grown 3.2× over the past decade, from $8.9M to $28.2M.
Context
Part of India's pharmaceutical supply network across Europe.
✦
Impact
A pharmaceutical relationship documented by both countries — verified trade data confirming the flow of affordable medicine.
Export Trend Eurostat CY DGCIS India-reported
Beyond Finished Medicines DGCIS CY 2014–2025

Additional pharmaceutical categories from DGCIS — APIs, surgical, herbal, and more

Category Mix — FY 2025–26 DGCIS
Medicines $43.5M (78.1%) Medicine Ingredients $7.3M (13.1%) Surgical & Hospital Supplies $3.9M (7.0%) Traditional & Herbal $1.0M (1.8%)
Top Products — FY 2025–26 DGCIS
Active Pharmaceutical Ingredients DGCIS India-side

India also supplied $8.4M in active pharmaceutical ingredients and bulk drugs to Denmark in 2025 (India-reported, DGCIS).

Global Pharma Thrives in India Source: OPPI / Annual Reports

The relationship flows both ways. Danish pharmaceutical companies are among the largest investors in India's health ecosystem — operating manufacturing plants, R&D centres, and clinical trial networks across the country.

Novo Nordisk
$42B global revenue
77,349 employees
Ozempic (Diabetes) · Wegovy (Obesity) · Rybelsus (Diabetes)